Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Climatic and social conditions drive the sale of paediatric dermatologicals products in Nigeria. As well as being more sensitive to environmental factors than adults, children’s lifestyles expose them to conditions that lead to skin problems,…
Dermatologicals is set to maintain a healthy growth trajectory in current value terms in Brazil in 2023, in line with the increase recorded in 2022, driven mainly by price rises. The pandemic years were marked by a reduction in Brazilians’ purchasing…
Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…
While overall consumer awareness of skin diseases and infections is increasing in Kenya, there remain areas where stigma persists, creating a reluctance among consumers to seek help. For instance, vaginal antifungals are linked to the stigma of…
Retail sales of dermatological products in Thailand experienced accelerated growth in current value terms in 2023, following the return of consumers to more active lifestyles outside the home. With this increased mobility came a greater risk of…
Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…
In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…
Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…
Dermatologicals has performed impressively in 2023, with all categories set to record stronger volume growth rates than in 2022. Demand for some product types has picked up as the increased levels of social contact brought about by the easing of the…
Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…
Dermatologicals is projected to continue to see positive, if slow, retail value (constant 2023 prices) growth in 2023. However, after posting robust retail volume gains in 2021 and 2022, most categories are projected to see declines in retail volume…
Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…
Dermatologicals again registered positive current value growth in 2023, continuing the trend of the previous years. The most dynamic category – hair loss treatments – continued to post strong growth. There are several reasons supporting the demand…
Topical antifungals was one of the most dynamic subcategories within dermatologicals in current value terms in 2023, continuing the trend of the previous year. Following a sluggish performance during the first three years of the review period, such…
The social restrictions in Singapore at the start of the pandemic led to less time spent outside the home, and therefore less concern about looks. This contributed to volume and current value declines for hair loss treatments and medicated shampoos…
Dermatologicals saw an overall increase in demand in 2023, although performance varied somewhat by subcategory Nappy (diaper) rash treatments, for example, benefited from the return of consumers to more active lifestyles outside the home, which meant…
Dermatologicals is set to see a strong performance in 2023, with all the major categories seeing mid to high single-digit growth in retail current value terms. Antifungals (topical antifungals and vaginal antifungals) is one of the largest categories…
After recording strong growth in 2022, sales of many dermatologicals in 2023 are weakening. Declining disposable incomes due to elevated inflation and higher interest rates are eroding the interest of Spaniards in spending on perceived non-essential…
Most types of dermatologicals saw an upward sales trend in retail volume terms in 2023, although the rate of expansion was lower than that seen in many other consumer health categories. Despite the increasing incidence of diagnosed skin diseases…
Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…
The above-average, high single-digit current value growth expected in topical germicidals/antiseptics in 2023 is also driving growth within overall dermatologicals in India, as this is the largest category. This surge in sales has been driven by…
Dermatologicals is a saturated category in South Korea and has lost some of its growth momentum in terms of retail volume sales. A lack of new product development is one factor hampering stronger growth for some products, whilst another is increasing…
Although dermatologicals continues to enjoy steady growth in 2023, current value sales have slowed down compared to the double-digit rates seen at the height of the COVID-19 pandemic. Whilst spending more time at home, Latvian consumers became…
Dermatologicals is expected to register moderate constant value growth in 2023. Geopolitical tensions in the region have led to a significant increase in the number of immigrants from Ukraine, Russia and Belarus, and this is expected to contribute to…
Dermatologicals is seeing solid current value growth in 2023, driven in part by higher retail prices. The category is benefiting from a return to normal daily lifestyles following the COVID-19 pandemic. Consumers’ skin is being more exposed to…
Value growth for dermatologicals continues to slow in 2023 as local consumers prioritise the treatment of other health concerns. According to a study led by the French Society of Dermatology (SFD), one in three French citizen suffers from a skin…
Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…
Dermatologicals is expected to register an increase in current value sales in 2023, partly as a result of the energy crisis stemming from the war in Ukraine, which is pushing up retail prices.
Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…
As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…
Dermatologicals is seeing mid-single digit growth in current value terms in 2023, although like many areas of consumer health this is largely the result of price increases. Prices have been rising across all categories of dermatologicals as a result…
Increasing consumer demand for medicated skin care products drives sales growth in dermatologicals in 2023. The aspiration for well-maintained and healthy skin is expanding from beauty and personal care to include dermatological products, as these…
The decline in consumers’ disposable income due to rising prices is dampening demand for consumer health products that are not seen as essential, such as many dermatologicals products. In the current economic climate in particular, Serbian consumers…
Dermatologicals, in some regards, are driven by environmental factors. As such, the emergence of the El Niño Costero climatological event, which increased temperatures in Peru, especially along the coast, ultimately resulted in a higher number of…
All dermatologicals categories in Hungary are expected to post negative results in volume terms in 2023, in most cases for the second year in a row. Although a number of different factors have depressed demand in individual categories, the overall…
In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer…
Healthy growth in dermatologicals is stemming from launches of value-added products. There was a pause on most new product development activity during the COVID-19 crisis, but with the end of the pandemic, products that had been held back have been…
The incidence of head lice is rising back to normal levels in 2023 as children circulate freely in schools and at social gatherings, and kids play close together. With retail volume sales back to pre-pandemic levels in 2022, demand for…
While sales of dermatologicals continue to grow in 2023, reflecting a recovery from pandemic-related disruptions. demand is stabilising. Mexicans are no longer facing increased risks to their skin compared to the previous year, and some…
Dermatologicals experienced a modest decline in overall constant value terms in 2023, although performance varied considerably according to subcategory. One notable development was the buoyant demand for antiparasitics/lice treatments, continuing the…
In line with the overall performance of skin care products in beauty and personal care in North Macedonia, dermatologicals is one of the fastest growing consumer health category thanks to strong and continued consumer demand. The product and brand…
Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…
2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…
Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…
Sales of dermatologicals strongly rely on consumers visiting pharmacies (the dominant distribution channel) as Belgians rarely go first to these stores specifically to purchase such products. Instead these are generally secondary purchases alongside…
Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…
Retail sales of dermatologicals showed moderate growth in current value terms in 2023, with inflationary pressures less severe but still a factor. The dermatological category in Uzbekistan is an area lacking in development, largely due to the limited…
Hair weakens and becomes vulnerable to shedding due to reasons like seasonality (seasonal transitions), stress, hormonal changes and thermal applications. For this reason, hair loss treatments tends to see increases in demand in spring and autumn,…
Hair loss treatments is expected to continue to see strong retail volume and current value growth over 2023. Indeed, hair loss treatments is projected to record the fastest retail volume growth at the end of the review period. Mild-to-severe hair…
The dermatologicals landscape is experiencing a downward momentum in some categories, which have found themselves losing share and importance following the outbreak of COVID-19. Topical Germicidals/Antiseptics is one of the categories which is set to…